BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 231 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $723,237 | -43.3% | 30,868 | -20.1% | 0.03% | -46.0% |
| Q1 2024 | $1,276,533 | -15.3% | 38,636 | -30.2% | 0.05% | -23.1% |
| Q4 2023 | $1,507,063 | +9.3% | 55,366 | -3.4% | 0.06% | -14.5% |
| Q3 2023 | $1,378,474 | -8.4% | 57,317 | +21.6% | 0.08% | -6.2% |
| Q2 2023 | $1,505,627 | +23.8% | 47,154 | +18.8% | 0.08% | +8.0% |
| Q1 2023 | $1,215,828 | +282.9% | 39,707 | +389.1% | 0.08% | +257.1% |
| Q4 2022 | $317,495 | -16.2% | 8,118 | +2.1% | 0.02% | -22.2% |
| Q3 2022 | $379,000 | +47.5% | 7,949 | +19.5% | 0.03% | +68.8% |
| Q2 2022 | $257,000 | -37.0% | 6,652 | -6.5% | 0.02% | -5.9% |
| Q1 2022 | $408,000 | -35.3% | 7,117 | -10.1% | 0.02% | -19.0% |
| Q4 2021 | $631,000 | -15.3% | 7,917 | -7.5% | 0.02% | -16.0% |
| Q3 2021 | $745,000 | – | 8,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |